[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Antidiabetic Biguanides Market Report 2018

April 2018 | 109 pages | ID: U8AC21697A8EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Antidiabetic Biguanides market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Antidiabetic Biguanides in these regions, from 2013 to 2025 (forecast).
United States Antidiabetic Biguanides market competition by top manufacturers/players, with Antidiabetic Biguanides sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Pfizer
  • AstraZeneca
  • GlaxoSmithKline
  • Merck & Co
  • Eli Lilly
  • Sanofi
  • Takeda Pharmaceuticals
  • Novo Nordisk
  • Servier Laboratories
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Metformin IR
  • Metformin SR
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospitals
  • Clinics
  • Other
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Antidiabetic Biguanides Market Report 2018

1 ANTIDIABETIC BIGUANIDES OVERVIEW

1.1 Product Overview and Scope of Antidiabetic Biguanides
1.2 Classification of Antidiabetic Biguanides by Product Category
  1.2.1 United States Antidiabetic Biguanides Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Antidiabetic Biguanides Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Metformin IR
  1.2.4 Metformin SR
1.3 United States Antidiabetic Biguanides Market by Application/End Users
  1.3.1 United States Antidiabetic Biguanides Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Other
1.4 United States Antidiabetic Biguanides Market by Region
  1.4.1 United States Antidiabetic Biguanides Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Antidiabetic Biguanides Status and Prospect (2013-2025)
  1.4.3 Southwest Antidiabetic Biguanides Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Antidiabetic Biguanides Status and Prospect (2013-2025)
  1.4.5 New England Antidiabetic Biguanides Status and Prospect (2013-2025)
  1.4.6 The South Antidiabetic Biguanides Status and Prospect (2013-2025)
  1.4.7 The Midwest Antidiabetic Biguanides Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Antidiabetic Biguanides (2013-2025)
  1.5.1 United States Antidiabetic Biguanides Sales and Growth Rate (2013-2025)
  1.5.2 United States Antidiabetic Biguanides Revenue and Growth Rate (2013-2025)

2 UNITED STATES ANTIDIABETIC BIGUANIDES MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Antidiabetic Biguanides Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Antidiabetic Biguanides Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Antidiabetic Biguanides Average Price by Players/Suppliers (2013-2018)
2.4 United States Antidiabetic Biguanides Market Competitive Situation and Trends
  2.4.1 United States Antidiabetic Biguanides Market Concentration Rate
  2.4.2 United States Antidiabetic Biguanides Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Antidiabetic Biguanides Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ANTIDIABETIC BIGUANIDES SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Antidiabetic Biguanides Sales and Market Share by Region (2013-2018)
3.2 United States Antidiabetic Biguanides Revenue and Market Share by Region (2013-2018)
3.3 United States Antidiabetic Biguanides Price by Region (2013-2018)

4 UNITED STATES ANTIDIABETIC BIGUANIDES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Antidiabetic Biguanides Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Antidiabetic Biguanides Revenue and Market Share by Type (2013-2018)
4.3 United States Antidiabetic Biguanides Price by Type (2013-2018)
4.4 United States Antidiabetic Biguanides Sales Growth Rate by Type (2013-2018)

5 UNITED STATES ANTIDIABETIC BIGUANIDES SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Antidiabetic Biguanides Sales and Market Share by Application (2013-2018)
5.2 United States Antidiabetic Biguanides Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANTIDIABETIC BIGUANIDES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Antidiabetic Biguanides Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 AstraZeneca
  6.2.2 Antidiabetic Biguanides Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 AstraZeneca Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 GlaxoSmithKline
  6.3.2 Antidiabetic Biguanides Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 GlaxoSmithKline Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Merck & Co
  6.4.2 Antidiabetic Biguanides Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Merck & Co Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Eli Lilly
  6.5.2 Antidiabetic Biguanides Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Eli Lilly Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Sanofi
  6.6.2 Antidiabetic Biguanides Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Sanofi Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Takeda Pharmaceuticals
  6.7.2 Antidiabetic Biguanides Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Takeda Pharmaceuticals Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Novo Nordisk
  6.8.2 Antidiabetic Biguanides Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Novo Nordisk Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Servier Laboratories
  6.9.2 Antidiabetic Biguanides Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Servier Laboratories Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Boehringer Ingelheim
  6.10.2 Antidiabetic Biguanides Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Boehringer Ingelheim Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Bristol-Myers Squibb

7 ANTIDIABETIC BIGUANIDES MANUFACTURING COST ANALYSIS

7.1 Antidiabetic Biguanides Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antidiabetic Biguanides

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Antidiabetic Biguanides Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antidiabetic Biguanides Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANTIDIABETIC BIGUANIDES MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Antidiabetic Biguanides Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Antidiabetic Biguanides Sales Volume Forecast by Type (2018-2025)
11.3 United States Antidiabetic Biguanides Sales Volume Forecast by Application (2018-2025)
11.4 United States Antidiabetic Biguanides Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Antidiabetic Biguanides
Figure United States Antidiabetic Biguanides Market Size (K Pcs) by Type (2013-2025)
Figure United States Antidiabetic Biguanides Sales Volume Market Share by Type (Product Category) in 2017
Figure Metformin IR Product Picture
Figure Metformin SR Product Picture
Figure United States Antidiabetic Biguanides Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Antidiabetic Biguanides by Application in 2017
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Antidiabetic Biguanides Market Size (Million USD) by Region (2013-2025)
Figure The West Antidiabetic Biguanides Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Antidiabetic Biguanides Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Antidiabetic Biguanides Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Antidiabetic Biguanides Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Antidiabetic Biguanides Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Antidiabetic Biguanides Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Antidiabetic Biguanides Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Antidiabetic Biguanides Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Antidiabetic Biguanides Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Antidiabetic Biguanides Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Antidiabetic Biguanides Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Antidiabetic Biguanides Sales Share by Players/Suppliers
Figure 2017 United States Antidiabetic Biguanides Sales Share by Players/Suppliers
Figure United States Antidiabetic Biguanides Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Antidiabetic Biguanides Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Antidiabetic Biguanides Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Antidiabetic Biguanides Revenue Share by Players/Suppliers
Figure 2017 United States Antidiabetic Biguanides Revenue Share by Players/Suppliers
Table United States Market Antidiabetic Biguanides Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Antidiabetic Biguanides Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Antidiabetic Biguanides Market Share of Top 3 Players/Suppliers
Figure United States Antidiabetic Biguanides Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Antidiabetic Biguanides Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Antidiabetic Biguanides Product Category
Table United States Antidiabetic Biguanides Sales (K Pcs) by Region (2013-2018)
Table United States Antidiabetic Biguanides Sales Share by Region (2013-2018)
Figure United States Antidiabetic Biguanides Sales Share by Region (2013-2018)
Figure United States Antidiabetic Biguanides Sales Market Share by Region in 2017
Table United States Antidiabetic Biguanides Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Antidiabetic Biguanides Revenue Share by Region (2013-2018)
Figure United States Antidiabetic Biguanides Revenue Market Share by Region (2013-2018)
Figure United States Antidiabetic Biguanides Revenue Market Share by Region in 2017
Table United States Antidiabetic Biguanides Price (USD/Pcs) by Region (2013-2018)
Table United States Antidiabetic Biguanides Sales (K Pcs) by Type (2013-2018)
Table United States Antidiabetic Biguanides Sales Share by Type (2013-2018)
Figure United States Antidiabetic Biguanides Sales Share by Type (2013-2018)
Figure United States Antidiabetic Biguanides Sales Market Share by Type in 2017
Table United States Antidiabetic Biguanides Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Antidiabetic Biguanides Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Antidiabetic Biguanides by Type (2013-2018)
Figure Revenue Market Share of Antidiabetic Biguanides by Type in 2017
Table United States Antidiabetic Biguanides Price (USD/Pcs) by Types (2013-2018)
Figure United States Antidiabetic Biguanides Sales Growth Rate by Type (2013-2018)
Table United States Antidiabetic Biguanides Sales (K Pcs) by Application (2013-2018)
Table United States Antidiabetic Biguanides Sales Market Share by Application (2013-2018)
Figure United States Antidiabetic Biguanides Sales Market Share by Application (2013-2018)
Figure United States Antidiabetic Biguanides Sales Market Share by Application in 2017
Table United States Antidiabetic Biguanides Sales Growth Rate by Application (2013-2018)
Figure United States Antidiabetic Biguanides Sales Growth Rate by Application (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Antidiabetic Biguanides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Pfizer Antidiabetic Biguanides Sales Growth Rate (2013-2018)
Figure Pfizer Antidiabetic Biguanides Sales Market Share in United States (2013-2018)
Figure Pfizer Antidiabetic Biguanides Revenue Market Share in United States (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca Antidiabetic Biguanides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure AstraZeneca Antidiabetic Biguanides Sales Growth Rate (2013-2018)
Figure AstraZeneca Antidiabetic Biguanides Sales Market Share in United States (2013-2018)
Figure AstraZeneca Antidiabetic Biguanides Revenue Market Share in United States (2013-2018)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Antidiabetic Biguanides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Antidiabetic Biguanides Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline Antidiabetic Biguanides Sales Market Share in United States (2013-2018)
Figure GlaxoSmithKline Antidiabetic Biguanides Revenue Market Share in United States (2013-2018)
Table Merck & Co Basic Information List
Table Merck & Co Antidiabetic Biguanides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Merck & Co Antidiabetic Biguanides Sales Growth Rate (2013-2018)
Figure Merck & Co Antidiabetic Biguanides Sales Market Share in United States (2013-2018)
Figure Merck & Co Antidiabetic Biguanides Revenue Market Share in United States (2013-2018)
Table Eli Lilly Basic Information List
Table Eli Lilly Antidiabetic Biguanides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Eli Lilly Antidiabetic Biguanides Sales Growth Rate (2013-2018)
Figure Eli Lilly Antidiabetic Biguanides Sales Market Share in United States (2013-2018)
Figure Eli Lilly Antidiabetic Biguanides Revenue Market Share in United States (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Antidiabetic Biguanides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Sanofi Antidiabetic Biguanides Sales Growth Rate (2013-2018)
Figure Sanofi Antidiabetic Biguanides Sales Market Share in United States (2013-2018)
Figure Sanofi Antidiabetic Biguanides Revenue Market Share in United States (2013-2018)
Table Takeda Pharmaceuticals Basic Information List
Table Takeda Pharmaceuticals Antidiabetic Biguanides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Takeda Pharmaceuticals Antidiabetic Biguanides Sales Growth Rate (2013-2018)
Figure Takeda Pharmaceuticals Antidiabetic Biguanides Sales Market Share in United States (2013-2018)
Figure Takeda Pharmaceuticals Antidiabetic Biguanides Revenue Market Share in United States (2013-2018)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Antidiabetic Biguanides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Novo Nordisk Antidiabetic Biguanides Sales Growth Rate (2013-2018)
Figure Novo Nordisk Antidiabetic Biguanides Sales Market Share in United States (2013-2018)
Figure Novo Nordisk Antidiabetic Biguanides Revenue Market Share in United States (2013-2018)
Table Servier Laboratories Basic Information List
Table Servier Laboratories Antidiabetic Biguanides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Servier Laboratories Antidiabetic Biguanides Sales Growth Rate (2013-2018)
Figure Servier Laboratories Antidiabetic Biguanides Sales Market Share in United States (2013-2018)
Figure Servier Laboratories Antidiabetic Biguanides Revenue Market Share in United States (2013-2018)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Antidiabetic Biguanides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim Antidiabetic Biguanides Sales Growth Rate (2013-2018)
Figure Boehringer Ingelheim Antidiabetic Biguanides Sales Market Share in United States (2013-2018)
Figure Boehringer Ingelheim Antidiabetic Biguanides Revenue Market Share in United States (2013-2018)
Table Bristol-Myers Squibb Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antidiabetic Biguanides
Figure Manufacturing Process Analysis of Antidiabetic Biguanides
Figure Antidiabetic Biguanides Industrial Chain Analysis
Table Raw Materials Sources of Antidiabetic Biguanides Major Players/Suppliers in 2017
Table Major Buyers of Antidiabetic Biguanides
Table Distributors/Traders List
Figure United States Antidiabetic Biguanides Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Antidiabetic Biguanides Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Antidiabetic Biguanides Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Antidiabetic Biguanides Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Antidiabetic Biguanides Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Antidiabetic Biguanides Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Antidiabetic Biguanides Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Antidiabetic Biguanides Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Antidiabetic Biguanides Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Antidiabetic Biguanides Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Antidiabetic Biguanides Sales Volume Share Forecast by Region (2018-2025)
Figure United States Antidiabetic Biguanides Sales Volume Share Forecast by Region (2018-2025)
Figure United States Antidiabetic Biguanides Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories